Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-17 9:31 pm Sale |
2025-03-13 | 13D | Innoviva, Inc. INVA |
Sarissa Capital Management LP | 2,966,022 4.700% |
-2,271,139 (-43.37%) |
Filing History |
| 2025-03-12 5:49 pm Unchanged |
2025-03-12 | 13D | Armata Pharmaceuticals, Inc. ARMP |
Innoviva Inc. INVA |
64,178,259 85.200% |
0 (Unchanged) |
Filing History |
| 2025-03-07 9:30 pm Sale |
2025-03-06 | 13D | Innoviva, Inc. INVA |
Sarissa Capital Management LP | 5,237,161 8.400% |
-1,666,839 (-24.14%) |
Filing History |
| 2025-02-11 09:12 am Sale |
2024-12-31 | 13G | Innoviva, Inc. INVA |
WESTFIELD CAPITAL MANAGEMENT CO LLC | 0 0.000% |
-4,106,136 (Position Closed) |
Filing History |
| 2025-01-27 1:04 pm Sale |
2024-12-31 | 13G | Innoviva, Inc. INVA |
FRANKLIN RESOURCES INC BEN |
4,432,301 7.100% |
-1,980,399 (-30.88%) |
Filing History |
| 2024-11-14 4:17 pm Unchanged |
2024-11-12 | 13D | Armata Pharmaceuticals, Inc. ARMP |
Innoviva Inc. INVA |
64,178,259 85.200% |
0 (Unchanged) |
Filing History |
| 2024-05-13 1:58 pm Unchanged |
2024-04-30 | 13G | Innoviva, Inc. INVA |
FRANKLIN RESOURCES INC BEN |
6,412,700 10.200% |
0 (Unchanged) |
Filing History |
| 2024-05-08 3:38 pm Purchase |
2024-04-30 | 13D | Innoviva, Inc. INVA |
FRANKLIN RESOURCES INC BEN |
6,412,700 10.200% |
6,412,700 (New Position) |
Filing History |
| 2024-03-04 5:35 pm Unchanged |
2024-03-04 | 13D | Armata Pharmaceuticals, Inc. ARMP |
Innoviva Inc. INVA |
64,178,259 85.300% |
0 (Unchanged) |
Filing History |
| 2024-02-14 07:23 am Purchase |
2023-12-31 | 13G | Innoviva, Inc. INVA |
PUTNAM INVESTMENTS LLC | 6,270,413 9.800% |
941,306 (+17.66%) |
Filing History |
| 2024-02-13 5:06 pm Sale |
2023-12-29 | 13G | Innoviva, Inc. INVA |
The Vanguard Group | 6,712,443 10.470% |
-359,769 (-5.09%) |
Filing History |
| 2024-02-13 10:26 am Sale |
2023-12-29 | 13G | Innoviva, Inc. INVA |
Renaissance Technologies LLC | 4,144,447 6.470% |
-85,160 (-2.01%) |
Filing History |
| 2024-02-09 09:59 am Purchase |
2024-02-14 | 13G | Innoviva, Inc. INVA |
DIMENSIONAL FUND ADVISORS INC | 4,516,999 7.000% |
4,516,999 (New Position) |
Filing History |
| 2024-01-22 2:03 pm Sale |
2023-12-31 | 13G | Innoviva, Inc. INVA |
BLACKROCK INC BLK |
10,349,116 16.100% |
-262,723 (-2.48%) |
Filing History |
| 2023-07-11 08:27 am Unchanged |
2023-07-10 | 13D | Armata Pharmaceuticals, Inc. ARMP |
Innoviva Inc. INVA |
64,178,259 85.300% |
0 (Unchanged) |
Filing History |
| 2023-05-15 5:05 pm Purchase |
2023-05-11 | 13D | Innoviva, Inc. INVA |
Sarissa Capital Management LP | 6,904,000 10.540% |
490,000 (+7.64%) |
Filing History |
| 2023-02-14 1:05 pm Purchase |
2022-12-31 | 13G | Innoviva, Inc. INVA |
PUTNAM INVESTMENTS LLC | 5,329,107 7.600% |
5,329,107 (New Position) |
Filing History |
| 2023-02-13 10:27 am Sale |
2022-12-30 | 13G | Innoviva, Inc. INVA |
Renaissance Technologies LLC | 4,229,607 6.060% |
-1,065,526 (-20.12%) |
Filing History |
| 2023-02-10 2:11 pm Unchanged |
2022-12-31 | 13G | Innoviva, Inc. INVA |
BLACKROCK INC BLK |
10,611,839 15.200% |
0 (Unchanged) |
Filing History |
| 2023-02-09 11:22 am Purchase |
2022-12-30 | 13G | Innoviva, Inc. INVA |
The Vanguard Group | 7,072,212 10.130% |
101,262 (+1.45%) |
Filing History |